Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Earnings Call Transcript

Page 7 of 7

Christine Sacco: Yes. We haven’t seen pushback from retailers on pricing. I guess the environment is such that everyone is facing inflationary pressures and everyone is going to retailers with the pricing and quite frankly, they have got cost inflation on the labor side and such for themselves. So, so far, we have not seen significant pushback from the retailers. No.

Unidentified Analyst: And just one more question, do you have any thoughts or initial thoughts on timing potentially on refinancing your 2024 term loan?

Ronald Lombardi: So the term loan goes through, I believe, 2027. So we will continue to kind of actively look at that, if you are referring to our revolver ABL that is maturing at the end of 2024 and we will continue to kind of look at that, but obviously a much different structure than the term loan, but we will be opportunistic on both.

Unidentified Analyst: Thank you very much.

Operator: Thank you and I’m seeing no further questions in the queue. I would now like to turn the conference back to Ron Lombardi for closing remarks.

Ronald Lombardi: Thank you, operator and thanks to everyone for joining us today and we look forward to providing an update in May on our first of fiscal 2023 and our outlook for fiscal 2024. Thanks again and have a good day.

Operator: This concludes today’s conference call. Thank you all for participating. You may now disconnect and have a pleasant day.

Follow Prestige Consumer Healthcare Inc. (NYSE:PBH)

Page 7 of 7